🔗 Share this article

The top legal official in Texas Paxton is suing the makers of Tylenol, alleging the corporations concealed alleged dangers that the medication created to pediatric cognitive development.

The lawsuit arrives a month after Donald Trump advocated an unverified association between taking Tylenol - alternatively called paracetamol - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing the pharmaceutical giant, which once produced the drug, the sole analgesic approved for expectant mothers, and Kenvue, which currently produces it.

In a declaration, he claimed they "misled consumers by profiting off of suffering and pushing pills regardless of the potential hazards."

The manufacturer says there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to increase profits," Paxton, from the Republican party, stated.

The company commented that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the likely effects that could have on the health of women and children in America."

On its online platform, Kenvue also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a verified association between consuming acetaminophen and autism."

Associations speaking for physicians and medical practitioners concur.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the key substance in acetaminophen - is one of the few options for expectant mothers to address pain and elevated temperature, which can pose serious health risks if ignored.

"In over twenty years of studies on the consumption of acetaminophen in gestation, not a single reputable study has definitively established that the consumption of acetaminophen in any trimester of pregnancy results in neurological conditions in children," the group commented.

The lawsuit mentions recent announcements from the former administration in asserting the medication is allegedly unsafe.

Last month, the former president raised alarms from public health officials when he advised expectant mothers to "resist strongly" not to take acetaminophen when sick.

The US Food and Drug Administration then issued a notice that doctors should think about restricting the consumption of Tylenol, while also stating that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in spring to conduct "comprehensive study program" that would establish the cause of autism in a limited time.

But specialists cautioned that discovering a sole reason of autism - thought by researchers to be the outcome of a intricate combination of inherited and external influences - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that affects how individuals perceive and engage with the surroundings, and is identified using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is seeking federal office - asserts Kenvue and J&J "willfully ignored and attempted to silence the science" around paracetamol and autism.

The case seeks to make the companies "destroy any promotional materials" that states Tylenol is secure for expectant mothers.

The court case echoes the concerns of a assembly of guardians of children with autism and ADHD who sued the manufacturers of Tylenol in two years ago.

The court threw out the legal action, declaring studies from the parents' expert witnesses was inconclusive.